skip to main content
Global Search Configuration

Using in-house sales forecasts, this analysis explores and visualizes market dynamics in the Big Pharma peer set out to 2025. PharmaVitae casts its eye out to 2025 as crystallizing trends in healthcare management will influence Big Pharma to further position itself towards providing value.

 

Big Pharma will add $39bn in revenues out to 2025, generating $464bn in prescription pharmaceuticals at a low single-digit compound annual growth rate of 0.9%. A healthy launch portfolio will bolster growth as Big Pharma reaps the reward of breakthrough products as the result of recent industry innovation. However, the low single-digit CAGR is representative of the overall drag that Big Pharma is facing. Three themes will shape the outlook: evolving business models, market access, and productivity.

 

 

Big Pharma Outlook 2025 - Sample Pages from Pharma Intelligence

 

Sign up to our Big Pharma Outlook 2026 webinar on the 29th June

 

 

Read also

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: